Pinned post
Thrilled to share the 1st paper from my lab @chemicalbiology cell.com/cell-chemical-… Rucaparib and its major metabolite have different activity that becomes synergistic in prostate cancer lines & active in a #Parkinson model @ICR_London @ProcureICO @ICO_oncologia @idibell_cat A🧵
www.cell.com Identification of differential biological activity and synergy between the PARP inhibitor rucaparib... Hu et al. comprehensively characterized the kinome profile of the major metabolite of rucaparib, M324. The study uncovers distinct kinase landscapes between rucaparib and M324 that translate into a...